These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 20199952)

  • 1. Comparative effectiveness research: Promising area of study for pharmacists.
    Clancy CM
    J Am Pharm Assoc (2003); 2010 Mar-Apr 1; 50(2):131-3. PubMed ID: 20199952
    [No Abstract]   [Full Text] [Related]  

  • 2. Spending limited health care dollars on what works best: the promise of comparative effectiveness research.
    Stein J
    N C Med J; 2010; 71(3):265-6. PubMed ID: 20681501
    [No Abstract]   [Full Text] [Related]  

  • 3. The relevance of international studies to informed pharmacoeconomics and health policy decisions.
    Lyles A
    Clin Ther; 2010 Jan; 32(1):106-7. PubMed ID: 20171416
    [No Abstract]   [Full Text] [Related]  

  • 4. The promise and future of comparative effectiveness research.
    Clancy CM
    J Nurs Care Qual; 2010; 25(1):1-4. PubMed ID: 20010250
    [No Abstract]   [Full Text] [Related]  

  • 5. A push for comparative effectiveness: US initiatives aim to empower patients, physicians. Interview by Bridget M. Kuehn.
    Clancy CM
    JAMA; 2012 Apr; 307(15):1570-1. PubMed ID: 22511672
    [No Abstract]   [Full Text] [Related]  

  • 6. Swimming upstream: comparative effectiveness research in the US.
    Greene JA
    Pharmacoeconomics; 2009; 27(12):979-82. PubMed ID: 19908922
    [No Abstract]   [Full Text] [Related]  

  • 7. The American Reinvestment and Recovery Act investment in comparative effectiveness research: lessons learned and implications for future investments.
    Dormer L; Greenfield S
    J Comp Eff Res; 2014 Nov; 3(6):559. PubMed ID: 25494558
    [No Abstract]   [Full Text] [Related]  

  • 8. Comments on 'Comparative effectiveness research: Policy context, methods development and research infrastructure'.
    Morton SC
    Stat Med; 2010 Aug; 29(19):1989-90; discussion 1996-7. PubMed ID: 20683889
    [No Abstract]   [Full Text] [Related]  

  • 9. Got CER? Educating Pharmacists for Practice in the Future: New Tools for New Challenges.
    Perfetto EM; Anyanwu C; Pickering MK; Zaghab RW; Graff JS; Eichelberger B
    J Manag Care Spec Pharm; 2016 Jun; 22(6):609-16. PubMed ID: 27231789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacists emerge as key stakeholders in quality, patient safety efforts.
    Kelly CY; Clancy CM
    J Am Pharm Assoc (2003); 2009; 49(2):146, 150. PubMed ID: 19289338
    [No Abstract]   [Full Text] [Related]  

  • 11. Science and the stiumulus. Medicine under the microscope.
    Marshall E
    Science; 2009 Nov; 326(5957):1183-5. PubMed ID: 19965447
    [No Abstract]   [Full Text] [Related]  

  • 12. Designing quality health services research: why comparative effectiveness studies are needed and why pharmacists should be involved.
    Carter BL
    Pharmacotherapy; 2010 Aug; 30(8):751-7. PubMed ID: 20653349
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparative effectiveness and real-world evidence.
    Leonard DT
    Am J Manag Care; 2010 Jun; 16(6):410-1. PubMed ID: 20560684
    [No Abstract]   [Full Text] [Related]  

  • 14. Charting a path from comparative effectiveness funding to improved patient-centered health care.
    Conway PH; Clancy C
    JAMA; 2010 Mar; 303(10):985-6. PubMed ID: 20215615
    [No Abstract]   [Full Text] [Related]  

  • 15. Guiding pharmacists to achieve success: our profession and APhA keep the light shining.
    Tucker TL
    J Am Pharm Assoc (2003); 2008; 48(4):460-3. PubMed ID: 18653419
    [No Abstract]   [Full Text] [Related]  

  • 16. Lessons from comparative effectiveness research methods development projects funded under the Recovery Act.
    Zurovac J; Esposito D
    J Comp Eff Res; 2014 Nov; 3(6):601-7. PubMed ID: 25494566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative effectiveness.
    Aston G
    Trustee; 2010 Jan; 63(1):13-4, 19-21. PubMed ID: 20143663
    [No Abstract]   [Full Text] [Related]  

  • 18. Facts, fallacies, and politics of comparative effectiveness research: Part I. Basic considerations.
    Manchikanti L; Falco FJ; Boswell MV; Hirsch JA
    Pain Physician; 2010; 13(1):E23-54. PubMed ID: 20119474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative Effectiveness Research in Pediatric Infectious Diseases.
    Hersh AL; Pavia AT
    J Pediatric Infect Dis Soc; 2015 Mar; 4(1):28-9. PubMed ID: 26407354
    [No Abstract]   [Full Text] [Related]  

  • 20. Pharmaceutical care and payment reform.
    Palumbo FB
    Am Pharm; 1994 Sep; NS34(9):4. PubMed ID: 7977026
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.